FDA CDS Software Regulation – Webinar Recording/Transcript
FDA CDS Software Regulation: The Latest Guidance on Clinical Decision Support Software
Want to attend the live webinar on April 7? Click here to register.
Does your software provide computerized alerts and reminders for providers and patients? Or clinical guidelines, condition-specific order set, focused patient data reports and summaries, documentation templates, diagnostic support or contextually relevant reference information?
If so, your clinical decision support (CDS) software might be regulated as a medical device.
You need to have a good grasp of the latest legal, regulatory and compliance nuances of FDA’s guidance on CDS software to be able to clarify the type of CDS software functions affected by legal developments like the 21st Century Cures Act.
Join FDAnews and legal expert Bradley Merrill Thompson for a comprehensive overview of current guidance on CDS software:
- Master the legal, regulatory, and compliance nuances of the FDA’s guidance
- Determine what types of CDS software functions do not meet the definition of a device as amended by the Cures Act
- Assess which types of software meet the definition of a device for which the FDA may not enforce compliance under device requirements
- Comprehend how the FDA intends to leverage the Software as a Medical Device: Possible Framework for Risk Categorization and Corresponding Considerations External Link Disclaimer(IMDRF Framework) in its risk-based approach to CDS regulation
Establish compliant best practices for your CDS software by understanding the legal, regulatory and compliance nuances of the FDA’s guidance.
Meet Your Presenter:
Bradley Merrill Thompson, Shareholder, Epstein Becker & Green, P.C.
Your webinar leader is Bradley Merrill Thompson, a shareholder in the national law firm of Epstein Becker & Green, P.C., based out of the firm’s Washington, D.C. office. He counsels software, medical device, and drug companies on a wide range of FDA regulatory issues and leads the firm’s AI practice.
Who Will Benefit
- Medical device companies
- Software manufacturers
- Quality, regulatory, and compliance specialists at medical device companies
- FDA attorneys